Overexpression of the Epidermal Growth Factor Receptor (EGFR) is one event linked to head and neck carcinogenesis and several EGFR-targeted therapies have been brought to clinical trials or approved in the case of cetuximab plus radiation [2], for the treatment of HNSCC. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.